Difficulties arising in reimbursement recommendations on new medicines due to inadequate reporting of population adjustment indirect comparison methods.
Res Synth Methods
; 10(4): 615-617, 2019 Dec.
Article
em En
| MEDLINE
| ID: mdl-31250534
ABSTRACT
Indirect treatment comparisons are useful to estimate relative treatment effects when head-to-head studies are not conducted. Statisticians at the National Centre for Pharmacoeconomics Ireland (NCPE) and Scottish Medicines Consortium (SMC) assess the clinical and cost-effectiveness of new medicines as part of multidisciplinary teams. We describe some shared observations on areas where reporting of population-adjustment indirect comparison methods is causing uncertainty in our recommendations to decision-making committees when assessing reimbursement of medicines.
Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Mecanismo de Reembolso
/
Projetos de Pesquisa
/
Coleta de Dados
/
Custos de Medicamentos
/
Análise Custo-Benefício
Tipo de estudo:
Guideline
/
Health_technology_assessment
/
Prognostic_studies
/
Risk_factors_studies
Limite:
Humans
País/Região como assunto:
Europa
Idioma:
En
Revista:
Res Synth Methods
Ano de publicação:
2019
Tipo de documento:
Article
País de afiliação:
Reino Unido